- Out-of-Stock
VLS Mounjaro Pen 20 mg (Tirzepatide) – UK, Europe & USA – SteroidUKShop
£165.00
No tax
Composition:
- Active Ingredient: Tirzepatide – 20 mg per pen (multi-dose delivering 4×5 mg doses)
- Form: Prefilled subcutaneous injection pen
- Vendor: Supplied by VLS under pharma-grade standards
Product Overview:
Tirzepatide (Eli Lilly’s Mounjaro) is a once-weekly injectable dual GIP/GLP‑1 receptor agonist approved for type 2 diabetes and weight management . It enhances insulin release, suppresses appetite, slows gastric emptying, and promotes significant blood sugar control and fat loss .
The VLS Mounjaro Pen at 20 mg (multi‑dose pen delivering four 5 mg doses) is ideal for ongoing dosing or dose escalation in a single package .
Key Benefits:
- Improves glycaemic control in type 2 diabetes
- Promotes substantial weight loss (e.g., ≥16 kg at 5 mg, more at higher doses)
- Dual action via GIP and GLP‑1 receptor stimulation enhances appetite suppression and fat metabolism
- Weekly dosing provides convenience and adherence
- May aid in metabolic health and body composition goals
Dosage & Usage:
- Starter Protocol: 2.5 mg subcutaneously once weekly for 4 weeks
- Maintenance Escalation: Increase by 2.5 mg every 4 weeks—typically through 5 mg → 7.5 mg → 10 mg, up to maximum typical use of 15 mg/week
- Use of 20 mg Pen: Contains four 5 mg doses; suitable for users on 5 mg dose level
- Injection Sites: Stomach, thigh, or upper arm; rotate injection site weekly
- Storage & Handling: Store pens refrigerated; allow to reach room temperature before injection
Shipping Information:
- UK: Next-day tracked delivery with temperature control
- Europe & USA: Discreet, insulated courier for peptide integrity
- Packaging: Unbranded, secure, and coded for privacy
Legal Disclaimer:
This product is intended for research and educational purposes only. Tirzepatide is a prescription-only medication (UK, EU, US licensed for diabetes and obesity). It is not intended to diagnose, treat, cure, or prevent any disease. Always consult a healthcare provider before initiating use.
Secure PaymentBank Transfer, Crypto
Fast Delivery1-3 Business days in UK. Worldwide shipping available.
Why Choose VLS Mounjaro Pen 20mg Tirzepatide?
You deserve nothing less than the finest when it comes to enhancing your health. The VLS Mounjaro Pen provides an easy-to-use and efficient method for reaching your objectives. This is why it is unique:
Convenience: Easy, precise dosage using a pre-filled pen.
Quick Results: Within weeks, there were observable changes in blood sugar and weight.
Safe and Dependable: Made in accordance with the strictest pharmaceutical guidelines.
How Tirzepatide Works
The beauty of Tirzepatide lies in its simplicity. It mimics natural hormones that regulate hunger, digestion, and blood sugar. Here’s how it helps:
1. Controls Appetite: Feel full faster and longer, reducing overeating.
2. Balances Blood Sugar: Enhances insulin function and reduces glucose spikes.
3. Burns Fat: Encourages your body to use fat stores as energy.
This multi-faceted approach makes Tirzepatide a powerful ally in both weight loss and diabetes management.
Key Benefits of VLS Mounjaro Pen
1. Notable Loss of Weight
Bid farewell to ineffective diets and welcome to steady, long-term weight loss. Within months, many users claim to have lost 15% or more of their body weight.
2. Better Regulation of Blood Sugar
Tirzepatide provides better glucose control for those with type 2 diabetes, which lessens the need for other drugs.
3. Less Cravings and Hunger
Tirzepatide suppresses hunger and cravings naturally, which helps you maintain healthy eating habits.
4. Enhanced Vitality
As your body maximizes its metabolism and consumes energy effectively, you'll feel more driven and energized.
How to Use the VLS Mounjaro Pen
Consistency and proper usage are crucial for achieving the best results.
1. Dosage:
- Start with a lower dose as recommended by your healthcare provider, typically 2.5mg per week.
- Gradually increase to 20mg per week over time, depending on tolerance and goals.
What to Stack with VLS Mounjaro Pen
For enhanced weight loss, consider stacking the VLS Mounjaro Pen with Clenbuterol 40mcg. This combination works synergistically to accelerate fat burning and improve overall results.
Best Dosage and PCT for Stacking
- Dosage:
- VLS Mounjaro Pen: 20mg per week.
- Clenbuterol: Start with 20mcg daily and gradually increase to 40mcg.
- PCT (Post Cycle Therapy):
- Not required for Tirzepatide or Clenbuterol, but focus on maintaining a clean diet, hydration, and regular physical activity for long-lasting results.
VLS001
Comments (0)
No customer reviews for the moment.
Customers who bought this product also bought:
Composition:
- Active Ingredient: Tirzepatide – 20 mg per pen (multi-dose delivering 4×5 mg doses)
- Form: Prefilled subcutaneous injection pen
- Vendor: Supplied by VLS under pharma-grade standards
Product Overview:
Tirzepatide (Eli Lilly’s Mounjaro) is a once-weekly injectable dual GIP/GLP‑1 receptor agonist approved for type 2 diabetes and weight management . It enhances insulin release, suppresses appetite, slows gastric emptying, and promotes significant blood sugar control and fat loss .
The VLS Mounjaro Pen at 20 mg (multi‑dose pen delivering four 5 mg doses) is ideal for ongoing dosing or dose escalation in a single package .
Key Benefits:
- Improves glycaemic control in type 2 diabetes
- Promotes substantial weight loss (e.g., ≥16 kg at 5 mg, more at higher doses)
- Dual action via GIP and GLP‑1 receptor stimulation enhances appetite suppression and fat metabolism
- Weekly dosing provides convenience and adherence
- May aid in metabolic health and body composition goals
Dosage & Usage:
- Starter Protocol: 2.5 mg subcutaneously once weekly for 4 weeks
- Maintenance Escalation: Increase by 2.5 mg every 4 weeks—typically through 5 mg → 7.5 mg → 10 mg, up to maximum typical use of 15 mg/week
- Use of 20 mg Pen: Contains four 5 mg doses; suitable for users on 5 mg dose level
- Injection Sites: Stomach, thigh, or upper arm; rotate injection site weekly
- Storage & Handling: Store pens refrigerated; allow to reach room temperature before injection
Shipping Information:
- UK: Next-day tracked delivery with temperature control
- Europe & USA: Discreet, insulated courier for peptide integrity
- Packaging: Unbranded, secure, and coded for privacy
Legal Disclaimer:
This product is intended for research and educational purposes only. Tirzepatide is a prescription-only medication (UK, EU, US licensed for diabetes and obesity). It is not intended to diagnose, treat, cure, or prevent any disease. Always consult a healthcare provider before initiating use.